Prostate health index could be used as an additional risk stratification tool for patients with Prostate Imaging Reporting and Data System score 3 lesions. Biopsies could be avoided in patients with low prostate health index, with a small risk of missing clinically significant prostate cancer....
The 4K score is a blood-based test, developed by OPKO Health Miami, FL, USA. Patients with abnormal PSA or DRE levels undergo a 4K score test to decide whether an initial biopsy is needed and patients for whom repeat biopsy is being considered. The possible candidates for this test are m...
Your Prostate Health Index test results will provide you with scores ranked as within range or out of range for the three tests that make up the phi score. These tests are: PSA: PSA (prostate specific antigen) is a protein that is produced by prostate cells. In this case, PSA represents...
Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostat... The cancer detection rates of clinically significant prostate cancer had statistically significant differences: 5.3% in prostate health index <25.0...
C. et al. Incorporating prostate health index density, MRI, and prior negative biopsy status to improve the detection of clinically significant prostate cancer. BJU Int. 12, 3218–3221 (2018). Google Scholar de Rooij, M. et al. Cost-effectiveness of magnetic resonance (MR) imaging and MR...
Several commercially available assays, including the Progensa PCA3 (Gen-Probe Inc), Prostate Health Index (PHI) (Beckman Coulter), and the 4K Score (OPKO Inc) have demonstrated varying efficacy to predict HG PCA but are potentially limited by cohort composition, inherent specificity issues of the...
Prostate Health Index, a test that combines total PSA, percent-free PSA, and another protein called proPSA. 4Kscore, a test that measures total PSA, percent-free PSA, intact PSA, and a protein called human kallikrein 2 (hK2). This test can help determine your risk of aggressive prostate ...
The Prostate Health Index (phi) exhibits significantly improved diagnostic accuracy for prostate cancer detection when compared to tPSA and %fPSA, however only one published study to date has investigated its impact on biopsy decisions in clinical practice.An IRB approved observational study was ...
Boegemann, M.et al. The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years.B...
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer: results from a multicentric European prospective study. Eur Urol. 2015;68(1):132-138. doi:10.1016/...